DE2661037C2 - - Google Patents

Info

Publication number
DE2661037C2
DE2661037C2 DE2661037A DE2661037A DE2661037C2 DE 2661037 C2 DE2661037 C2 DE 2661037C2 DE 2661037 A DE2661037 A DE 2661037A DE 2661037 A DE2661037 A DE 2661037A DE 2661037 C2 DE2661037 C2 DE 2661037C2
Authority
DE
Germany
Prior art keywords
flunisolide
propellant
aerosol
powder
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2661037A
Other languages
German (de)
English (en)
Inventor
John H. Palo Alto Calif. Us Fried
Richard E. Woodside Calif. Us Jones
Gisela T. Cupertino Calif. Us Haringer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of DE2661037C2 publication Critical patent/DE2661037C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DE2661037A 1975-05-27 1976-06-03 Expired DE2661037C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (1)

Publication Number Publication Date
DE2661037C2 true DE2661037C2 (sv) 1989-04-06

Family

ID=27078279

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2624924A Expired DE2624924C2 (de) 1975-05-27 1976-06-03 Verfahren zur Herstellung einer neuen kristallinen Form von Flunisolid und diese enthaltende Aerosolzusammnesetzung
DE2661037A Expired DE2661037C2 (sv) 1975-05-27 1976-06-03

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2624924A Expired DE2624924C2 (de) 1975-05-27 1976-06-03 Verfahren zur Herstellung einer neuen kristallinen Form von Flunisolid und diese enthaltende Aerosolzusammnesetzung

Country Status (15)

Country Link
JP (1) JPS51144719A (sv)
AT (1) AT357702B (sv)
AU (1) AU506080B2 (sv)
CA (1) CA1075228A (sv)
DE (2) DE2624924C2 (sv)
ES (1) ES448220A1 (sv)
FR (1) FR2361900A1 (sv)
GB (1) GB1525181A (sv)
HK (1) HK8580A (sv)
IL (1) IL49652A (sv)
MX (1) MX3864E (sv)
MY (1) MY8000275A (sv)
NL (1) NL191234C (sv)
NZ (1) NZ180946A (sv)
SE (1) SE421426B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162530C (da) * 1979-05-21 1992-03-30 Syntex Corp Fremgangsmaade til fremstilling af en krystallinsk modifikation af flunisolid
EP0039369B1 (en) * 1980-05-02 1983-06-15 Schering Corporation Beclomethasone ester solvates, process for their preparation, and preparation of a formulation
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
JP2843857B2 (ja) * 1988-10-05 1999-01-06 ファルマシア・アンド・アップジョン・カンパニー 反溶剤への沈澱を介する微細分化固体結晶性粉末
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
EE03509B2 (et) * 1995-06-27 2015-02-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Stabiilsed ravimikompositsioonid kandegaasita aerosoolide saamiseks
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
AU2000250701B2 (en) 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
JP6473134B2 (ja) * 2013-03-15 2019-02-20 メディシス ファーマシューティカル コーポレイション フルニソリドの局所用組成物および治療方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
DE2320111A1 (de) * 1972-04-20 1973-10-31 Allen & Hanburys Ltd Solvatisierte, kristalline, antiinflammatorisch wirkende steroide, verfahren zu deren herstellung und diese materialien enthaltende aerosolformulierungen
DE2332663A1 (de) * 1973-06-23 1975-01-16 Schering Ag Kortikoidhaltige inhalationsmittel
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB933868A (en) * 1958-12-08 1963-08-14 American Cyanamid Co Process for fluorinating steroids

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
DE2320111A1 (de) * 1972-04-20 1973-10-31 Allen & Hanburys Ltd Solvatisierte, kristalline, antiinflammatorisch wirkende steroide, verfahren zu deren herstellung und diese materialien enthaltende aerosolformulierungen
DE2332663A1 (de) * 1973-06-23 1975-01-16 Schering Ag Kortikoidhaltige inhalationsmittel
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Disease 109, 1974, S.538-543 *
J. Allergy 33, 1, 1974, S.1-5 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole

Also Published As

Publication number Publication date
CA1075228A (en) 1980-04-08
SE421426B (sv) 1981-12-21
NL191234C (nl) 1995-04-03
SE7605927L (sv) 1976-11-28
GB1525181A (en) 1978-09-20
AU506080B2 (en) 1979-12-13
NZ180946A (en) 1978-07-28
JPS6247880B2 (sv) 1987-10-09
MY8000275A (en) 1980-12-31
DE2624924C2 (de) 1986-11-27
NL7605699A (nl) 1976-11-30
AU1430176A (en) 1977-12-01
JPS51144719A (en) 1976-12-13
ATA388376A (de) 1979-12-15
MX3864E (es) 1981-08-26
FR2361900B1 (sv) 1979-04-13
FR2361900A1 (fr) 1978-03-17
HK8580A (en) 1980-03-14
ES448220A1 (es) 1977-11-01
IL49652A (en) 1979-05-31
NL191234B (nl) 1994-11-01
IL49652A0 (en) 1976-07-30
AT357702B (de) 1980-07-25
DE2624924A1 (de) 1977-12-15

Similar Documents

Publication Publication Date Title
DE2661037C2 (sv)
DE69938390T2 (de) Verwendung einer zusammensetzung welche formoterol und budesonide enthält, zur verhinderung oder behandlung eines akuten astmazustandes
DE69928665T2 (de) Kortikosteroide enthaltende wässrige Zusammensetzungen zum nasalen oder pulmonalen Zuführen
EP1014943B1 (de) Medizinische aerosolformulierungen
EP1102579B1 (de) Medizinische aerosolformulierungen
EP1372608B1 (de) Medizinische aerosolformulierungen
DE69936730T2 (de) Lösungsaerosolzusammensetzungen, die HFA227 und HFA 134a enthalten
DE69232818T2 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
DE60131881T2 (de) Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid
DE69821796T2 (de) Sterilisation von glucocorticosteroiden
DE69935002T2 (de) Verfahren zur Herstellung eines sterilen therapeutisch verträglichen Beclomethasondipropionats
DE69834955T2 (de) Neue Verwendung von Budesonide und Formoterol
DE69807420T3 (de) Pharmazeutische aerosolzusammensetzung
DE60001492T2 (de) Pharmazeutische aerosolformulierung
DE60019167T2 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
DE69528769T2 (de) Aerosolformulierung für arzneimittel enthaltend polyglycolisierte glyzeride
DE2703119C2 (sv)
EP0504112A2 (de) Pharmazeutische Aerosolformulierungen
WO2000006121A1 (de) Medizinische aerosolformulierungen
EP0655237A1 (de) Medizinische Aerosolformulierung
DE602005003138T3 (de) Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase
DE69705628T2 (de) Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
EP0605483B1 (de) Treibmittel für aerosole und dosieraerosole
DE60311665T2 (de) Pharmazeutische zusammensetzungen
DE102012102218A1 (de) Ozon nicht abbauende medizinische Aerosolformulierungen

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2624924

8110 Request for examination paragraph 44
8181 Inventor (new situation)

Free format text: FRIED, JOHN H., PALO ALTO, CALIF., US JONES, RICHARD E., WOODSIDE, CALIF., US HARINGER, GISELA T., CUPERTINO, CALIF., US

AC Divided out of

Ref country code: DE

Ref document number: 2624924

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition